We are live on
!
Find out more
ACA
Atlas Capital Advisors Portfolio holdings
AUM
$875M
This Fund
S&P 500
This Quarter
Est. Return
-11.35%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$250M
AUM Growth
-$50.1M
(-17%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-40.59%
Top 10 Holdings %
Top 10 Hldgs %
19.69%
Holding
626
New
90
Increased
123
Reduced
203
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.53M |
| 2 |
Johnson & Johnson
JNJ
|
+$1.48M |
| 3 |
Vanguard Health Care ETF
VHT
|
+$1.4M |
| 4 |
Pfizer
PFE
|
+$1.4M |
| 5 |
FedEx
FDX
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$93M |
| 2 |
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
|
+$2.23M |
| 3 |
Vanguard Communication Services ETF
VOX
|
+$1.5M |
| 4 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$1.34M |
| 5 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.19% |
| 2 | Financials | 8.92% |
| 3 | Technology | 8.82% |
| 4 | Consumer Staples | 7.16% |
| 5 | Consumer Discretionary | 5.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PVH
PVH
$3.99B
| $249K | 0.1% |
2,675
+1,015
| +61% | +$116K |
|
227
Mitsubishi UFJ Financial
MUFG
$254B
| $248K | 0.1% |
50,909
-12,081
| -19% | -$68.4K |
|
228
Capri Holdings
CPRI
$1.7B
| $246K | 0.1% |
6,484
+5,430
| +515% | +$273K |
|
229
DXC Technology
DXC
$1.77B
| $246K | 0.1% |
4,619
+1,117
| +32% | +$77.2K |
|
230
Huntington Bancshares
HBAN
$35.1B
| $230K | 0.09% |
19,274
-7,428
| -28% | -$103K |
|
|
UPM
231
DELISTED
UPM-KYMMRME ADR (REPR ORD SHS)
UPM
| $228K | 0.09% |
8,876
| – | – |
|
232
iShares MSCI Finland ETF
EFNL
$247M
| $221K | 0.09% |
6,214
| – | – |
|
233
Estee Lauder
EL
$30.9B
| $221K | 0.09% |
1,695
-934
| -36% | -$127K |
|
234
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| $219K | 0.09% |
1,658
+59
| +4% | +$8.59K |
|
235
STMicroelectronics
STM
$47.5B
| $219K | 0.09% |
15,750
-1,840
| -10% | -$27.6K |
|
236
Warner Bros
WBD
$66.2B
| $218K | 0.09% |
+8,808
| New | +$268K |
|
237
Humana
HUM
$44.1B
| $216K | 0.09% |
754
-69
| -8% | -$21.9K |
|
238
TE Connectivity
TEL
$62.3B
| $215K | 0.09% |
2,839
-3,244
| -53% | -$250K |
|
239
American Tower
AMT
$79.8B
| $214K | 0.09% |
1,350
| – | – |
|
240
American Express
AXP
$231B
| $214K | 0.09% |
2,240
+949
| +74% | +$99.3K |
|
241
ArcelorMittal
MT
$55.2B
| $211K | 0.08% |
10,185
-176
| -2% | -$4.36K |
|
242
Goodyear
GT
$1.94B
| $210K | 0.08% |
10,270
+9,188
| +849% | +$199K |
|
243
Thermo Fisher Scientific
TMO
$214B
| $207K | 0.08% |
923
+48
| +5% | +$11.3K |
|
244
Sumitomo Mitsui Financial
SMFG
$163B
| $204K | 0.08% |
31,356
-16,860
| -35% | -$126K |
|
245
GSK
GSK
$104B
| $200K | 0.08% |
+4,196
| New | +$207K |
|
246
Take-Two Interactive
TTWO
$43.5B
| $200K | 0.08% |
1,946
-240
| -11% | -$27.6K |
|
|
KYO
247
DELISTED
Kyocera Adr
KYO
| $196K | 0.08% |
3,929
| – | – |
|
248
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.95B
| $193K | 0.08% |
9,778
| – | – |
|
249
Unilever
UL
$137B
| $190K | 0.08% |
+3,228
| New | +$195K |
|
250
Arthur J. Gallagher & Co
AJG
$64.5B
| $189K | 0.08% |
+2,562
| New | +$191K |
|
Similar funds
MC
AGDI
SA
F1I
HT
OHA
WCM
AE
Atlas Capital Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Atlas Capital Advisors held 626 positions worth $250M, down 17% from $300M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Atlas Capital Advisors withdrew a net $101M in Q4 2018, closing 65 positions and reducing 203 holdings. Its most notable exit was Red Hat Inc, an estimated $708K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 8.6% a quarter earlier, followed by Financials and Technology.
Against the trend, Atlas Capital Advisors opened a new position in Schwab US Mid-Cap ETF worth $939K.
- Atlas Capital Advisors's largest Q4 2018 buy was Schwab US Mid-Cap ETF: 58,785 shares worth $939K.
- Atlas Capital Advisors added most to CVS Health in Q4 2018, an estimated $1.53M increase.
- Atlas Capital Advisors's biggest Q4 2018 reduction was Berkshire Hathaway Class A, cutting an estimated $93M.
- Atlas Capital Advisors fully exited Red Hat Inc in Q4 2018, selling an estimated $708K.
- Atlas Capital Advisors's ten largest holdings make up 20% of its $250M portfolio in Q4 2018.
- Atlas Capital Advisors opened 90 new positions and closed 65 in Q4 2018.
- Atlas Capital Advisors's portfolio value fell 17% quarter-over-quarter to $250M.
Based on Atlas Capital Advisors's 13F filing for Q4 2018, filed 29 Jan 2019.